These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24522743)

  • 21. Antiemetic research: future directions.
    Olver I; Molassiotis A; Aapro M; Herrstedt J; Grunberg S; Morrow G
    Support Care Cancer; 2011 Mar; 19 Suppl 1():S49-55. PubMed ID: 21063733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prophylaxis of acute chemotherapy-induced nausea and vomiting in children with cancer: what is the evidence?
    Antonarakis ES; Evans JL; Heard GF; Noonan LM; Pizer BL; Hain RD
    Pediatr Blood Cancer; 2004 Nov; 43(6):651-8. PubMed ID: 15390297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiemetic therapy for multiple-day chemotherapy and additional topics consisting of rescue antiemetics and high-dose chemotherapy with stem cell transplant: review and consensus statement.
    Einhorn LH; Grunberg SM; Rapoport B; Rittenberg C; Feyer P
    Support Care Cancer; 2011 Mar; 19 Suppl 1():S1-4. PubMed ID: 20505956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of anti-emetic use in chemotherapy-induced nausea and vomiting in a third-world country (Lebanon).
    Zeitoun AA; Nassif JG
    J Eval Clin Pract; 2013 Feb; 19(1):68-75. PubMed ID: 21999252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update.
    Hesketh PJ; Kris MG; Basch E; Bohlke K; Barbour SY; Clark-Snow RA; Danso MA; Dennis K; Dupuis LL; Dusetzina SB; Eng C; Feyer PC; Jordan K; Noonan K; Sparacio D; Somerfield MR; Lyman GH
    J Clin Oncol; 2017 Oct; 35(28):3240-3261. PubMed ID: 28759346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A retrospective review of antiemetic use for chemotherapy-induced nausea and vomiting in pediatric oncology patients at a tertiary care center.
    Aseeri M; Mukhtar A; Al Khansa S; Elimam N; Jastaniah W
    J Oncol Pharm Pract; 2013 Jun; 19(2):138-44. PubMed ID: 23034405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiemetic prophylaxis and frequency of chemotherapy-induced nausea and vomiting in palliative first-line treatment of colorectal cancer patients: the Northern Bavarian IVOPAK I Project.
    Koch S; Wein A; Siebler J; Boxberger F; Neurath MF; Harich HD; Hohenberger W; Dörje F
    Support Care Cancer; 2013 Sep; 21(9):2395-402. PubMed ID: 23568765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Japanese Society of Clinical Oncology clinical practice guidelines 2010 for antiemesis in oncology: executive summary.
    Takeuchi H; Saeki T; Aiba K; Tamura K; Aogi K; Eguchi K; Okita K; Kagami Y; Tanaka R; Nakagawa K; Fujii H; Boku N; Wada M; Akechi T; Udagawa Y; Okawa Y; Onozawa Y; Sasaki H; Shima Y; Shimoyama N; Takeda M; Nishidate T; Yamamoto A; Ikeda T; Hirata K
    Int J Clin Oncol; 2016 Feb; 21(1):1-12. PubMed ID: 26081252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prophylaxis of chemotherapy-induced vomiting and nausea].
    Tóth J; Szántó J
    Magy Onkol; 2008 Dec; 52(4):391-4. PubMed ID: 19068468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pattern of prophylaxis administration for chemotherapy-induced nausea and vomiting: an analysis of city-based health insurance data.
    Nakamura F; Higashi T
    Int J Clin Oncol; 2013 Dec; 18(6):971-6. PubMed ID: 23011102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative Cost-utility Analysis Between Aprepitant- and Fosaprepitant-containing Regimens To Prevent Chemotherapy-induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy in Japan.
    Kashiwa M; Matsushita R
    Clin Ther; 2019 May; 41(5):929-942. PubMed ID: 31036286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ten-Year Trends in Antiemetic Prescribing in Patients Receiving Highly Emetogenic Chemotherapy.
    O'Sullivan CC; Van Houten HK; Sangaralingham LR; Leal AD; Shinde S; Liu H; Ettinger D; Loprinzi CL; Ruddy KJ
    J Natl Compr Canc Netw; 2018 Mar; 16(3):294-299. PubMed ID: 29523668
    [No Abstract]   [Full Text] [Related]  

  • 33. Chemotherapy-induced nausea and vomiting in daily clinical practice: a community hospital-based study.
    Hilarius DL; Kloeg PH; van der Wall E; van den Heuvel JJ; Gundy CM; Aaronson NK
    Support Care Cancer; 2012 Jan; 20(1):107-17. PubMed ID: 21258948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2016 Updated MASCC/ESMO Consensus Recommendations: Controlling nausea and vomiting with chemotherapy of low or minimal emetic potential.
    Olver I; Ruhlmann CH; Jahn F; Schwartzberg L; Rapoport B; Rittenberg CN; Clark-Snow R
    Support Care Cancer; 2017 Jan; 25(1):297-301. PubMed ID: 27572335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breakthrough chemotherapy-induced nausea and vomiting: report of a nationwide survey by the CINV Study Group of Japan.
    Tamura K; Aiba K; Saeki T; Nakanishi Y; Kamura T; Baba H; Yoshida K; Yamamoto N; Kitagawa Y; Maehara Y; Shimokawa M; Hirata K; Kitajima M;
    Int J Clin Oncol; 2017 Apr; 22(2):405-412. PubMed ID: 27909835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An effective five-drug antiemetic combination for prevention of chemotherapy-related nausea and vomiting. Experience in eighty-four patients.
    Kessler JF; Alberts DS; Plezia PM; Wilson V; Chase J; Aapro M; Surwit EA
    Cancer Chemother Pharmacol; 1986; 16(3):282-6. PubMed ID: 3698169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Olanzapine as antiemetic drug in oncology: a retrospective study in non-responders to standard antiemetic therapy.
    Slimano F; Netzer F; Borget I; Lemare F; Besse B
    Int J Clin Pharm; 2018 Oct; 40(5):1265-1271. PubMed ID: 29744791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Nationwide, Multicenter Registry Study of Antiemesis for Carboplatin-Based Chemotherapy-Induced Nausea and Vomiting in Japan.
    Iihara H; Shimokawa M; Hayashi T; Kawazoe H; Saeki T; Aiba K; Tamura K
    Oncologist; 2020 Feb; 25(2):e373-e380. PubMed ID: 32043774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of single-dose oral granisetron versus intravenous ondansetron in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy: a multicenter, double-blind, randomized parallel study.
    Perez EA; Hesketh P; Sandbach J; Reeves J; Chawla S; Markman M; Hainsworth J; Bushnell W; Friedman C
    J Clin Oncol; 1998 Feb; 16(2):754-60. PubMed ID: 9469367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-emetic drugs in oncology: pharmacology and individualization by pharmacogenetics.
    Perwitasari DA; Gelderblom H; Atthobari J; Mustofa M; Dwiprahasto I; Nortier JW; Guchelaar HJ
    Int J Clin Pharm; 2011 Feb; 33(1):33-43. PubMed ID: 21365391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.